Skip Nav Destination
1-4 of 4
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
A Retrospective Real-World Study of the Current Treatment Pathways for Myelofibrosis in the UK (The REALISM UK Study)
Adam J. Mead, MD PhD, Tim Somervaille, Professor, MD, Nauman M Butt, MD, Waseem Nagi, MD FRCPath, Alastair J Whiteway, MBBS, Suriya Kirkpatrick, MD, Ciro R Rinaldi, MD PhD, Catherine Roughley, MD, Sam Ackroyd, MD, Joanne Ewing, PhDBMBS BSc FRPATH, Pratap Neelakantan, MD FRCPath, Mamta Garg, MD FRCP, FRCPath, Claire N Harrison, Professor, David Tucker, MD, Rozinder Bains, Gavin Chiu, MBBS, MRCGP, MFPM, DPM, BSc, Joe Hickey, PhD
Blood (2019) 134 (Supplement_1): 1671.
Elevated Labile Plasma Iron (LPI) Levels in Patients with Lower-Risk Myelodysplastic Syndromes (MDS) Are Associated with Decreased Quality of Life and Reduced Survival
Marlijn Hoeks, MD, Tim Bagguley, MS, Rian Roelofs, Msc, Louise De Swart, MD, David Bowen, MD PhD, Argiris Symeonidis, MD PhD, Corine van Marrewijk, PhD, Eva Hellström-Lindberg, MD PhD, Aurelia Tatic, MD, Saskia Langemeijer, MD PhD, Dominic J. Culligan, Marian Macheta, MD, Hege Garelius, MD, Michail Spanoudakis, MD, Sally Killick, MD, Panagiotis Panagiotidis, MD PhD, Oana Stanca Ciocan, MD, Juliet Mills, MD, Bryson Pottinger, Sam Ackroyd, MD, Claire Hall, MD, Jackie Droste, PhD, Alexandra Smith, PhD, Dorine W. Swinkels, MD PhD, Theo M de Witte, MD
Blood (2018) 132 (Supplement 1): 4392.
SAMHD1 is mutated recurrently in chronic lymphocytic leukemia and is involved in response to DNA damage
Ruth Clifford, Tania Louis, Pauline Robbe, Sam Ackroyd, Adam Burns, Adele T. Timbs, Glen Wright Colopy, Helene Dreau, Francois Sigaux, Jean Gabriel Judde, Margalida Rotger, Amalio Telenti, Yea-Lih Lin, Philippe Pasero, Jonathan Maelfait, Michalis Titsias, Dena R. Cohen, Shirley J. Henderson, Mark T. Ross, David Bentley, Peter Hillmen, Andrew Pettitt, Jan Rehwinkel, Samantha J. L. Knight, Jenny C. Taylor, Yanick J. Crow, Monsef Benkirane, Anna Schuh
Blood (2014) 123 (7): 1021–1031.
Includes: Supplemental data
SAMHD1, A Putative Tumour Suppressor, Is Recurrently Mutated in Chronic Lymphocytic Leukaemia, and Is Associated with Poor Risk Features
Ruth Clifford, Sam Ackroyd, Adam Burns, Adele Timbs, Jonathan Maelfait, Helene Dreau, Shirley Henderson, Mark Ross, David Bentley, Peter Hillmen, MBChB, PhD, Samantha Knight, Jenny Taylor, Chris S.R Hatton, Jan Rehwinkel, Yanick Crow, Anna Schuh
Blood (2012) 120 (21): 713.